Platelet-rich plasma versus hyaluronic acid for the treatment of knee osteoarthritis: A meta-analysis

孙红,苏蒙召,胥泽玺,彭国璇,邓进,宁旭,杨华
DOI: https://doi.org/10.3877/cma.j.issn.2096-0263.2022.01.008
2022-01-01
Abstract:Objective:This study aimed to evaluate the clinical efficacy of platelet-rich plasma (PRP) injection compared with hyaluronic acid (HA) injection for the treatment of patients diagnosed with knee osteoarthritis (KOA).Methods:Online databases including PubMed, Embase, Ovid and, Cochrane Library, CNKI and Wanfang database were systematically searched to collect the random controlled trials (RCT) comparing the clinical efficacy between PRP and HA in the treatment of KOA. The primary outcomes were Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and function score. Secondary outcomes were WOMAC total score, WOMAC stiffness score, International Knee Documentation Committee (IKDC) score, visual analog scale (VAS) score, EuroQol (EQ)-VAS score, Knee and Osteoarthritis Outcome System (KOOS) score, Lequesne Index score and adverse events. The pooled results were calculated by Review Manager 5.3.Results:A total of 19 RCTs were enrolled in present study. The pooled results demonstrated that PRP injection was more effective than HA injection in pain relief at 6-month and 12-month of follow-up evaluated by WOMAC pain score and VAS score. EQ-VAS score in the patients treated with PRP injection was lower than that in patients with HA injection at 12-month. Moreover, the patients with PRP injection had a better function recovery than those with HA injection at 1 month, 3-month, 6-month and 12-month after surgery, as evaluated by WOMAC function score. WOMAC total score showed significant difference at 6-months and 12-month after surgery. The IKDC score indicated PRP injection was significantly more effective than HA injection at 3-month and 6-month after surgery. However, the Lequesne Index score, KOOS score and adverse events didn't show any significant difference between the groups.Conclusions:Intra-articular PRP injection appeared to be more efficacy than HA injection for the treatment of KOA in terms of short-term functional recovery. Moreover, PRP injection was superior to HA injection in terms of long-term pain relief and function improvement. In addition, PRP injection didn't increase the risk of adverse events compared to HA injection.
What problem does this paper attempt to address?